Government of Croatia   Report issue

Government Phase 2 Phase 4
Founded: Zagreb Croatia (Hrvatska) (1990)

Organization Overview

First Clinical Trial
2006
NCT00290173
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Ministry of Science, Education and Sport, Republic of Croatia

Active Ingredients

Drugs in Phase 4 Trials (1)

clopidogrel (plavix) (1 trial)

Drugs in Phase 2 Trials (2)

betamethasone (celestone) (1 trial)

naphthalan (1 trial)

Drugs in Other Trials (1)

ritodrine (yutopar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Lichen Planus (Phase 2)

Lichen Planus, Oral (Phase 2)

Stomatitis (Phase 2)

Stomatitis, Aphthous (Phase 2)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4